C12N 2501/2312
Interleukin-12
Official title: Interleukin-12 (IL-12)
C12N2501/2312 (Interleukin-12) appears on 103 US grants and 269 published applications in this corpus.
Search patents in C12N- Granted patents
- 103
- Published applications
- 269
- Assignees
- 150
- Inventors
- 538
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 3 |
| 2014 | 2 | 6 |
| 2015 | 2 | 6 |
| 2016 | 0 | 7 |
| 2017 | 5 | 12 |
| 2018 | 5 | 15 |
| 2019 | 9 | 24 |
| 2020 | 18 | 26 |
| 2021 | 14 | 37 |
| 2022 | 4 | 27 |
| 2023 | 9 | 26 |
| 2024 | 15 | 30 |
| 2025 | 16 | 32 |
| 2026 | 4 | 15 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Media and methods for differentiating natural killer cells1 Sep 2026US 12,723,233 B2Stemcell Technologies Canada Inc.
- Method for increasing dendritic cell migration ability, and use thereof14 Apr 2026US 12,600,946 B2Cha University Industry-Academic Cooperation Foundation
- Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy31 Mar 2026US 12,590,148 B2Nkarta, Inc.
- Immune cell function17 Feb 2026US 12,551,530 B2Kite Pharma, Inc.
- Method for producing memory-like NK cells with ability to express higher levels of NCRs, cytotoxicity, and IFN-γ than NK cells in human peripheral blood2 Dec 2025US 12,486,492 B2Korea Research Institute of Bioscience
- Compositions comprising and methods of using dendritic cell exosomes8 Oct 2026US 2026/0308524 A1Baylor College of Medicine
- Method for producing car-t cells23 Jul 2026US 2026/0209704 A1Takeda Pharmaceutical Company Limited
- Two-dimensional processes for the expansion of tumor infiltrating lymphocytes and therapies therefrom9 Jul 2026US 2026/0193606 A1Iovance Biotherapeutics, Inc.
- Production method for proliferative myeloid cells constitutively producing il-12p702 Jul 2026US 2026/0185047 A1Beijing Tianyifang Bio. Dev. Co., Ltd.
- Expansion of gamma delta t cells, compositions, and methods of use thereof25 Jun 2026US 2026/0174861 A1GammaDelta Therapeutics Ltd
Most cited
By later US patents
- Handheld electromechanical surgical system627US 10,932,784 B2Covidien LP · 2021
- Multi-chain chimeric polypeptides and uses thereof15US 11,738,052 B2HCW Biologics, Inc. · 2023
- Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance14US 10,669,528 B2Children's Medical Center Corporation · 2020
- Generation of HPV-specific T-cells12US 9,642,906 B2Baylor College of Medicine · 2017
- IL-9 secreting CD8+ Tc9 cells and methods of treating cancer11US 9,694,033 B2The Cleveland Clinic Foundation · 2017